Lung cancer/Pulmonary nodule
Conditions
Interventions
Patients with lung cancer were inoculated with any kind of SARS-CoV-2 Vaccination:Nil
Patients with pulmonary nodules receive either of the SARS-CoV-2 Vaccination:Nil
Healthy subjects were inoculated with any type of SARS-CoV-2 Vaccination:Nil
Patients with pulmonary nodules who have not received SARS-CoV-2 Vaccination:Nil
Sponsors
Guangdong Provincial People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Pulmonary nodule/lung cancer patients confirmed by CT or pathological examination, who have been vaccinated against the SARS-CoV-2; 2. Pulmonary nodule/lung cancer patients confirmed by CT or pathological examination, who are not vaccinated against the SARS-CoV-2; 3. Healthy people who have been vaccinated against the SARS-CoV-2.
Exclusion criteria
Exclusion criteria: 1. Multiple malignancy in other parts of body; 2. Infected with SARS-CoV-2 virus currently or in the past; 3. Refuse to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Odd ratio of vaccination-related symptoms; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to progression of pulmonary nodule; | — |
Countries
China
Contacts
Public ContactQiao Guibin
Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences
Outcome results
None listed